- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 931
Tokopedia locks up $1bn in SoftBank-led round
SoftBank has reportedly led a round that valued the peer-to-peer e-commerce platform, which also counts Alibaba and CyberAgent as investors, at about $7bn.
Nov 21, 2018Finleap jumps on $47m
Ping An has led a $47.3m investment in Finleap through its Global Voyager Fund, joining a list of shareholders that already included Hannover Re and Signal Iduna.
Nov 21, 2018MapAnything drives away with series C funding
The geolocation software provider received $42.5m in a round that included GM Ventures and Salesforce Ventures, taking its total funding to about $83m.
Nov 21, 2018Inflazome gets series B funding influx
Inflammatory disease drug developer Inflazome, based on research at University of Queensland and Trinity College Dublin, has added $45.6m in series B capital to its coffers.
Nov 21, 2018BillDesk itemises $300m Visa investment
Visa has provided a reported $200m in equity funding for bill payment platform BillDesk and bought up to $100m worth of shares in a secondary transaction.
Nov 20, 2018Corporates take Leap in $288m series A
Leap Motor has received $288m in a round co-led by Shanghai Electric and CRRC as it prepares to launch its smart electric sports car early next year.
Nov 20, 2018Acorns to manage $100m investment
PayPal and Rakuten-backed savings platform Acorns Grow is looking to raise more than $100m in a corporate-led round that will value it at $700m.
Nov 20, 2018Xiaoqule bands together investors to raise $108m
The community-focused e-commerce platform has raised series A funds from investors including Ping An Ventures and SIG Asia.
Nov 20, 2018Vascugen generates funding
Vascugen has collected an undisclosed sum from investors including Indiana University Philanthropic Venture Fund to commercialise medicines for vascular-degenerative diseases based on IU technology.
Nov 20, 2018Novartis and Clal help inject $40m into Cadent
Novartis and Access Industries unit Clal Biotechnology Industries both took part in the neurological disorder drug developer's series B round.
Nov 20, 2018About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


